Emergency endovascular treatment of stroke due to cervical artery dissection – impact of periprocedural GP IIb/IIIa inhibitor use on clinical outcome
In this study, the use of a GP IIb/IIIa inhibitor use during EVT for stroke caused by CeAD did not affect 90-day clinical outcome nor the incidence of intracranial hemorrhage. Successful reperfusion significantly correlated with favorable clinical outcome.
Authors
- Miranda Stattmann
- Miklós Krepuska (ORCID: https://orcid.org/0000-0003-0635-358X)
- Tilman B. Schubert (ORCID: https://orcid.org/0000-0003-2373-5870)
- Patrick Thurner (ORCID: https://orcid.org/0000-0003-3966-5520)
- Andreas R. Luft (ORCID: https://orcid.org/0000-0001-9865-7382)
- Zsolt Kulcsár (ORCID: https://orcid.org/0000-0002-6805-5150)
- Jawid Madjidyar (ORCID: https://orcid.org/0000-0003-1413-3069)
- Christoph Globas (ORCID: https://orcid.org/0000-0002-2355-1150)
- Susanne Wegener (ORCID: https://orcid.org/0000-0003-4369-7023)
- Jil Baumann
- Hakim Shakir Husain
- Abira Sornalingam
Institutions
- University Hospital of Zurich (CH)
- Kerala Institute of Medical Sciences (IN)
- Baby Memorial Hospital (IN)
- Cereneo (CH)
Publication Details
- Journal
- CVIR Endovascular
- Published
- 2025-05-22
- DOI
- https://doi.org/10.1186/s42155-025-00564-9
- Citations
- 1
- Primary Topic
- Acute Ischemic Stroke Management
- Type
- article
- Field-Weighted Citation Impact
- 1.35